Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.

PloS One
Karin ForsbergThomas Brännström

Abstract

Mutations in CuZn-superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS) and are found in 6% of ALS patients. Non-native and aggregation-prone forms of mutant SOD1s are thought to trigger the disease. Two sets of novel antibodies, raised in rabbits and chicken, against peptides spaced along the human SOD1 sequence, were by enzyme-linked immunosorbent assay and an immunocapture method shown to be specific for denatured SOD1. These were used to examine SOD1 in spinal cords of ALS patients lacking mutations in the enzyme. Small granular SOD1-immunoreactive inclusions were found in spinal motoneurons of all 37 sporadic and familial ALS patients studied, but only sparsely in 3 of 28 neurodegenerative and 2 of 19 non-neurological control patients. The granular inclusions were by confocal microscopy found to partly colocalize with markers for lysosomes but not with inclusions containing TAR DNA binding protein-43, ubiquitin or markers for endoplasmic reticulum, autophagosomes or mitochondria. Granular inclusions were also found in carriers of SOD1 mutations and in spinobulbar muscular atrophy (SBMA) patients and they were the major type of inclusion detected in ALS patients homozygous for the wild type-like D90A mutatio...Continue Reading

References

Oct 1, 1984·The Journal of Clinical Investigation·S L Marklund
May 1, 1995·Journal of Neurochemistry·A C BowlingR H Brown
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·P PasinelliD W Cleveland
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·S KatoE Ohama
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joan Selverstone Valentine, P John Hart
Sep 26, 2003·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Peter M AndersenRobert H Brown
Oct 10, 2003·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Jun 26, 2004·Annual Review of Neuroscience·Lucie I BruijnDon W Cleveland
May 10, 2005·Muscle & Nerve·Christine M WooleyKevin L Seburn
Jul 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mikael J LindbergMikael Oliveberg
Dec 7, 2005·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Han-Xiang DengTeepu Siddique
Dec 6, 2006·Journal of Neuropathology and Experimental Neurology·P Andreas JonssonStefan L Marklund
Jul 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Arie GruzmanJian Liu
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Per ZetterströmStefan L Marklund
Aug 26, 2009·Neurobiology of Disease·P Andreas JonssonThomas Brännström

❮ Previous
Next ❯

Citations

Jan 8, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Priyanka PatelJean-Pierre Julien
Apr 11, 2014·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Lucia BanciEnrico Ravera
Dec 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Magdalena I IvanovaDavid S Eisenberg
Jan 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Kathrin MeyerBrian K Kaspar
Sep 7, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kevin D FoustBrian K Kaspar
Jan 21, 2014·Antioxidants & Redox Signaling·Chris McKinnon, Sarah J Tabrizi
Mar 28, 2013·Oxidative Medicine and Cellular Longevity·Sonam ParakhJulie D Atkin
Nov 15, 2013·Clinical & Developmental Immunology·Kristen MarciniukScott Napper
Nov 11, 2010·Journal of Neuroinflammation·Milan FialaMartina Wiedau-Pazos
Jun 28, 2011·The Journal of Biological Chemistry·Jens DanielssonMikael Oliveberg
Jul 12, 2011·Biochemistry·Rachel L RedlerNikolay V Dokholyan
Aug 17, 2011·Cold Spring Harbor Perspectives in Biology·Daryl A BoscoDagmar Ringe
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Leslie I GradNeil R Cashman
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Atanu Das, Steven S Plotkin
Sep 21, 2013·International Journal of Molecular Sciences·Joana S CristóvãoCláudio M Gomes
Oct 13, 2011·Nature Reviews. Neurology·Peter M Andersen, Ammar Al-Chalabi
Nov 19, 2011·Molecular Neurodegeneration·Mercedes Prudencio, David R Borchelt
Jun 15, 2013·Cellular and Molecular Life Sciences : CMLS·Vinod SundaramoorthyJulie D Atkin
Oct 19, 2012·Neuromolecular Medicine·Per ZetterströmStefan L Marklund
Jul 13, 2013·The Journal of Physical Chemistry. B·Anna BilleAnders Irbäck
Sep 28, 2013·Der Nervenarzt·A HübersA C Ludolph
Jul 26, 2012·Neurology Research International·Yoshiaki Furukawa
May 19, 2012·Human Molecular Genetics·Matthis SynofzikPeter M Andersen
Oct 3, 2012·Human Molecular Genetics·Karin S GraffmoThomas Brännström
Jun 6, 2013·Human Molecular Genetics·Sarah PicklesChristine Vande Velde
May 21, 2013·Brain : a Journal of Neurology·Rachele A SacconPietro Fratta
Feb 18, 2016·Medical Hypotheses·D Toscano-TejeidaE Meléndez-Herrera
May 12, 2015·Expert Opinion on Biological Therapy·Joseph M ScarrottMimoun Azzouz
Apr 5, 2012·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Sarah Pickles, Christine Vande Velde
Oct 31, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Nov 11, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Sep 13, 2015·Protein Science : a Publication of the Protein Society·Helen R BroomElizabeth M Meiering
Jan 27, 2016·Acta Neuropathologica Communications·Eiichi TokudaStefan L Marklund
Nov 14, 2015·Advances in Biological Regulation·Yuki HayashiHidenori Ichijo
May 24, 2011·Neurology Research International·Pamela MilaniCristina Cereda

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
confocal microscopy
transgenic

Software Mentioned

SPSS
STATISTICA

Related Concepts

Related Feeds

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Related Papers

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
Masamitsu YaguchiKoichi Okamoto
Journal of Neuropathology and Experimental Neurology
P Andreas JonssonStefan L Marklund
© 2021 Meta ULC. All rights reserved